Almonty's Balancing Act: Buyback Ambitions Meet a New Production Era at Sangdong
Published on 08/22/2026 at 17:31 | Redaktion boerse-global.de
The tungsten producer now juggling a $300 million share repurchase program has quietly kept the door open for fresh equity issuance — a two-pronged capital strategy that arrives just as the company's flagship Korean mine transitions from construction site to operating asset.
Almonty Industries' board signed off on the buyback on August 17, authorizing the repurchase of up to 14.4 million common shares — roughly five percent of the stock outstanding as of August 14 — over a 36-month window running from August 24, 2026 through August 24, 2029. Management framed the decision in terms of a disconnect between the market price and the underlying value of its tungsten assets, particularly with the Sangdong processing facility now ramping toward full throughput.
Yet the timing is anything but one-directional. In August, the company also filed shelf registrations covering the potential issuance of new common shares worth approximately $246.79 million, including a component earmarked for an employee share participation program. A shelf registration is a legal mechanism rather than an immediate capital raise — it simply creates the option to move quickly should the need arise, whether for expansion or the employee scheme. Still, the juxtaposition of buying shares off the market while keeping an issuance pipeline warm raises legitimate questions about how both pieces fit within a coherent capital discipline framework.
A Mine Comes to Life
The operational narrative, meanwhile, has shifted decisively. On Thursday, Almonty began feeding a 139,700-tonne ore stockpile with a blended grade of 0.25 percent tungsten trioxide into the newly commissioned mill at Sangdong in South Korea — the moment the company stopped being a development story and became a producer with direct revenue relevance. Sangdong ranks among the most significant tungsten deposits outside China, and the move from construction to material throughput fundamentally recasts the company's profile.
The second-quarter numbers, released August 11, underscore the scale of that transition. Revenue surged 498 percent year-over-year to C$43.0 million, while net income swung to C$181.8 million from a C$58.2 million loss in the prior-year quarter. Adjusted EBITDA landed at C$17.6 million. Earnings per share of C$0.62 blew past the consensus estimate of C$0.10, though revenue of C$43.0 million — reported in US dollars in the earnings release — came in just shy of the C$45.7 million analysts had penciled in.
Should investors sell immediately? Or is it worth buying Almonty?
Balance Sheet Backing
The financial firepower behind these maneuvers has expanded markedly. Following the completion on June 9 of an oversubscribed $800 million convertible bond placement — carrying a 2.25 percent coupon and maturing in 2031 — Almonty held roughly C$1.23 billion in cash as of June 30. That liquidity cushion explains how the company can entertain both a billion-dollar-scale buyback framework and a capital-raising option without the two necessarily colliding.
Operating cash flow also turned positive in the first half, swinging to an inflow of C$31.6 million from an outflow of C$14.9 million in the comparable period a year earlier. The company has used some of that balance sheet strength to tidy up its financing structure: the KfW loan has been fully repaid — a step taken roughly a month ago, since which the shares have given back 21.3 percent — and the offtake agreement with Global Tungsten & Powders LLC has been extended to a 21-year term with contracted volumes increased by 40 percent.
One detail worth flagging amid the buyback announcement: director Mark Trachuk disposed of 200,000 common shares in early July at $24.070 apiece, a transaction worth $4,814,000 that reduced his stake by 7.4 percent. Insider selling alongside a large repurchase program is not inherently alarming, but it merits attention when a company is simultaneously signaling that its own stock looks undervalued.
Consolidating the Listing
The corporate structure is being streamlined in parallel. After voluntarily delisting from the Toronto Stock Exchange on July 31, the CDIs traded on the Australian exchange are set to be suspended at the close of trading on August 28, with the full ASX delisting scheduled for September 1. The rationale: liquidity has become overwhelmingly concentrated on the Nasdaq, where the bulk of daily trading volume now occurs, while TSX and ASX activity had dwindled noticeably. The CDIs held on the Australian register represented just 0.80 percent of issued shares as of July 14.
Following the delistings, trading will center on the Nasdaq under the ticker "ALM" and on the Frankfurt exchange under "ALI1." The company also entered the large-cap Russell 1000 and the broader Russell 3000 at the end of June as part of the index reconstitution.
The threads now converge on a single question: whether Sangdong's throughput ramp can translate these structural and financial shifts into sustained revenue and earnings growth over the coming quarters. The pieces are in place — a producing asset, a fortified balance sheet, a concentrated listing — but the mill's output will ultimately determine whether the strategy holds together.
Ad
Almonty Stock: New Analysis - 22 August
Fresh Almonty information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
